Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Calcium modulators and the gut: an update.

G B Glavin1

  • 1Department of Pharmacology and Therapeutics, Faculty of Medicine, University of Manitoba, Winnipeg, Canada.

Methods and Findings in Experimental and Clinical Pharmacology
|July 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Isolated rat gastric mucosal cells: optimal conditions for cell harvesting, measures of viability and direct cytoprotection.

The Journal of pharmacology and experimental therapeutics·1996
Same author

Effects of a novel 5-HT1A receptor agonist, E4424, on gastric adherent mucus levels following restraint stress in rats.

Digestive diseases and sciences·1995
Same author

Central and peripheral dopamine D1/DA1 receptor modulation of gastric secretion and experimental gastric mucosal injury.

General pharmacology·1995
Same author

Efaroxan acts peripherally to block the antisecretory and gastroprotective effects of moxonidine in rats.

The Journal of pharmacology and experimental therapeutics·1995
Same author

Agmatine, an endogenous imidazoline receptor agonist, increases gastric secretion and worsens experimental gastric mucosal injury in rats.

The Journal of pharmacology and experimental therapeutics·1995
Same author

Moxonidine decreases gastric secretion and gastric mucosal injury in rats.

Annals of the New York Academy of Sciences·1995

Calcium plays a key role in gut secretion. Calcium channel blockers and chelators impact gut ulcers and secretion, offering potential therapeutic avenues for gastrointestinal disorders.

Area of Science:

  • Gastroenterology and Pharmacology

Background:

  • Calcium is essential for cellular stimulus-secretion coupling in the gut.
  • Emerging research indicates that calcium-modulating compounds influence gastrointestinal functions in vivo.

Purpose of the Study:

  • To investigate the effects of calcium channel blockers and calcium chelators on gastric secretion and mucosal injury.
  • To explore the potential of calcium-modulating agents as therapeutic strategies for gastrointestinal disorders.

Main Methods:

  • Administration of dihydropyridine calcium channel blockers.
  • Administration of calcium chelating compounds (EDTA, EGTA).
  • Assessment of anti-secretory and gastroprotective effects in experimental ulcer models.

Main Results:

  • Dihydropyridine calcium channel blockers demonstrated anti-secretory and anti-stress ulcer effects.

Related Experiment Videos

  • These same calcium channel blockers worsened ethanol-induced gastric mucosal injury.
  • Calcium chelators (EDTA, EGTA) reduced experimental ulcers and gastric secretion.

    • Conclusions:

    • Calcium-modulating agents, including channel blockers and chelators, exhibit significant effects on gastric secretion and mucosal protection.
    • Potential mechanisms involve neural, hormonal, peptide, and enzymatic pathways.
    • These compounds represent a promising area for developing novel gastrointestinal therapeutics.